CXHL1700361 | CS3001 | CS3001 | Active ingredient | Chemical Drugs(1) | New Drug Application | 2018-06-06 | 基石药业(苏州)有限公司 | Cornerstone Pharmaceutical (Suzhou) Co Ltd | In Review | 2018-06-04 | view |
CXHL1700362 | CS3001片 | CS3001 | Tablet | Chemical Drugs(1) | New Drug Application | 2018-06-06 | 基石药业(苏州)有限公司 | Cornerstone Pharmaceutical (Suzhou) Co Ltd | Certificate Issued | 2018-10-15 | view |
CXHL1700363 | CS3001片 | CS3001 | Tablet | Chemical Drugs(1) | New Drug Application | 2018-06-06 | 基石药业(苏州)有限公司 | Cornerstone Pharmaceutical (Suzhou) Co Ltd | Certificate Issued | 2018-10-15 | view |
CXHL1800062 | CS3006 | CS3006 | Active ingredient | Chemical Drugs(1) | New Drug Application | 2018-04-25 | 基石药业(苏州)有限公司 | Cornerstone Pharmaceutical (Suzhou) Co Ltd | In Review | 2018-04-23 | view |
CXHL1800063 | CS3006片 | CS3006 | Tablet | Chemical Drugs(1) | New Drug Application | 2018-04-25 | 基石药业(苏州)有限公司 | Cornerstone Pharmaceutical (Suzhou) Co Ltd | Certificate Issued | 2018-07-13 | view |
CXHL1800064 | CS3006片 | CS3006 | Tablet | Chemical Drugs(1) | New Drug Application | 2018-04-25 | 基石药业(苏州)有限公司 | Cornerstone Pharmaceutical (Suzhou) Co Ltd | Certificate Issued | 2018-07-13 | view |
CXHL1900010 | CS3003 | CS3003 | Active ingredient | Chemical Drugs(1) | New Drug Application | 2019-01-11 | 基石药业(苏州)有限公司 | Cornerstone Pharmaceutical (Suzhou) Co Ltd | In Review | 2019-01-10 | view |
CXHL1900011 | CS3003片 | CS3003 | Tablet | Chemical Drugs(1) | New Drug Application | 2019-01-11 | 基石药业(苏州)有限公司 | Cornerstone Pharmaceutical (Suzhou) Co Ltd | In Review | 2019-01-10 | view |
CXHL1900013 | CS3003片 | CS3003 | Tablet | Chemical Drugs(1) | New Drug Application | 2019-01-11 | 基石药业(苏州)有限公司 | Cornerstone Pharmaceutical (Suzhou) Co Ltd | In Review | 2019-01-10 | view |
CXHL1900415 | CS3002片 | CS3002 | Tablet | Chemical Drugs(1) | New Drug Application | 2019-12-17 | 基石药业(苏州)有限公司 | Cornerstone Pharmaceutical (Suzhou) Co Ltd | In Review | 2019-12-16 | view |
CXHL1900416 | CS3002片 | CS3002 | Tablet | Chemical Drugs(1) | New Drug Application | 2019-12-17 | 基石药业(苏州)有限公司 | Cornerstone Pharmaceutical (Suzhou) Co Ltd | In Review | 2019-12-16 | view |
CXHL1900417 | CS3002片 | CS3002 | Tablet | Chemical Drugs(1) | New Drug Application | 2019-12-17 | 基石药业(苏州)有限公司 | Cornerstone Pharmaceutical (Suzhou) Co Ltd | In Review | 2019-12-16 | view |
CXHL2000070 | CS3005片 | CS3005 | Tablet | Chemical Drugs(1) | New Drug Application | 2020-03-06 | 基石药业(苏州)有限公司 | Cornerstone Pharmaceutical (Suzhou) Co Ltd | In Review | 2020-03-05 | view |
CXHL2000071 | CS3005片 | CS3005 | Tablet | Chemical Drugs(1) | New Drug Application | 2020-03-06 | 基石药业(苏州)有限公司 | Cornerstone Pharmaceutical (Suzhou) Co Ltd | In Review | 2020-03-05 | view |
CXSB1800001 | 重组抗PD-L1全人单克隆抗体注射液 | Recombinant anti-PD-L1 human monoclonal antibody | Injection | Biological Products | Supplementary Application | 2018-01-26 | 基石药业(苏州)有限公司 | Cornerstone Pharmaceutical (Suzhou) Co Ltd | Certificate Issued | 2018-06-28 | view |
CXSL1600075 | 重组抗PD-L1全人单克隆抗体注射液 | Recombinant anti-PD-L1 human monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2016-10-11 | 基石药业(苏州)有限公司 | Cornerstone Pharmaceutical (Suzhou) Co Ltd | Certificate Issued | 2017-07-17 | view |
CXSL1700212 | CS1002注射液 | Ipilimumab | Injection | Biological Products(2) | New Drug Application | 2018-03-01 | 基石药业(苏州)有限公司 | Cornerstone Pharmaceutical (Suzhou) Co Ltd | Certificate Issued | 2018-08-13 | view |
CXSL1800027 | CS1003注射液 | CS1003 | Injection | Biological Products(1) | New Drug Application | 2018-03-13 | 基石药业(苏州)有限公司 | Cornerstone Pharmaceutical (Suzhou) Co Ltd | Certificate Issued | 2018-07-06 | view |
CXSL1900011 | 重组抗PD-L1全人单克隆抗体注射液 | Recombinant anti-PD-L1 human monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2019-02-12 | 基石药业(苏州)有限公司 | Cornerstone Pharmaceutical (Suzhou) Co Ltd | In Review | 2019-02-11 | view |
CXSL1900017 | 重组抗PD-L1全人单克隆抗体注射液 | Recombinant anti-PD-L1 human monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2019-03-07 | 基石药业(苏州)有限公司 | Cornerstone Pharmaceutical (Suzhou) Co Ltd | In Review | 2019-03-06 | view |